DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - MIRUM PHARMACEUTICALS INC ownership

MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 99 filers reported holding MIRUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.7%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of MIRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$48,816,687
+23.2%
2,032,3350.0%1.09%
+32.7%
Q4 2022$39,630,533
-7.2%
2,032,3350.0%0.82%
-3.5%
Q3 2022$42,699,000
-32.4%
2,032,335
-37.4%
0.85%
-34.7%
Q2 2022$63,137,000
-12.7%
3,244,434
-1.2%
1.30%
-19.4%
Q1 2022$72,290,000
+38.1%
3,282,9120.0%1.62%
+47.2%
Q4 2021$52,362,000
-19.9%
3,282,9120.0%1.10%
-13.9%
Q3 2021$65,396,000
+9.7%
3,282,912
-4.8%
1.28%
+20.5%
Q2 2021$59,632,000
-12.8%
3,448,9120.0%1.06%
-26.3%
Q1 2021$68,357,000
+13.5%
3,448,9120.0%1.44%
+20.8%
Q4 2020$60,218,000
-9.4%
3,448,9120.0%1.19%
-26.5%
Q3 2020$66,461,000
-1.0%
3,448,9120.0%1.62%
-17.2%
Q2 2020$67,116,000
+39.0%
3,448,9120.0%1.96%
+27.6%
Q1 2020$48,285,000
-42.9%
3,448,9120.0%1.53%
-43.2%
Q4 2019$84,567,000
+143.7%
3,448,9120.0%2.70%
+90.7%
Q3 2019$34,696,0003,448,9121.42%
Other shareholders
MIRUM PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Frazier Life Sciences Management, L.P. 6,470,392$204,464,38713.58%
NEA Management Company, LLC 2,186,243$69,085,2795.34%
TANG CAPITAL MANAGEMENT LLC 1,137,107$35,932,5815.07%
BOONE CAPITAL MANAGEMENT LLC 389,791$12,317,3963.89%
Highlander Partners, L.P. 122,980$3,886,1683.84%
BVF INC/IL 4,370,024$138,092,7583.72%
Prosight Management, LP 353,508$11,170,8533.54%
Novo Holdings A/S 1,500,000$47,400,0003.50%
Nicholas Investment Partners, LP 1,199,366$37,899,9662.83%
Eventide Asset Management 3,958,579$125,091,0972.25%
View complete list of MIRUM PHARMACEUTICALS INC shareholders